Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use ZUNVEYL safely and effectively. See full prescribing information for ZUNVEYL. ZUNVEYL (benzgalantamine) delayed-release tablets, for oral use Initial U.S. Approval: 2001
Medication labelWhy this: Advisory · dailymed-prescription
ZUNVEYL is indicated for the treatment of mild to moderate dementia of the Alzheimer's type in adults.
- generic_name
- benzgalantamine
- product_names
- benzgalantamine
- ndc
- 84054-005, 84054-005-60, 84054-005-14, 84054-010, 84054-010-60, 84054-010-14, 84054-015, 84054-015-60
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en